VIVO
VIVO Real Time Price USDRecent trades of VIVO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by VIVO's directors and management
Government lobbying spending instances
-
$10,000 Jan 19, 2023 Issue: Health Issues
-
$10,000 Apr 20, 2022 Issue: Health Issues
-
$10,000 Jan 20, 2022 Issue: HEALTH ISSUES
-
$10,000 Oct 20, 2021 Issue: HEALTH ISSUES
-
$10,000 Jul 19, 2021 Issue: HEALTH ISSUES
-
$10,000 Apr 20, 2021 Issue: HEALTH ISSUES
-
$20,000 Jan 14, 2021 Issue: HEALTH ISSUES
-
$20,000 Oct 05, 2020 Issue: HEALTH ISSUES
-
$20,000 Jul 06, 2020 Issue: HEALTH ISSUES
-
$20,000 Apr 02, 2020 Issue: HEALTH ISSUES
-
$20,000 Jan 08, 2020 Issue: HEALTH ISSUES
-
$20,000 Jul 02, 2019 Issue: Health Issues
-
$20,000 Apr 02, 2019 Issue: Health Issues
-
$20,000 Jan 08, 2019 Issue: Health Issues
-
$20,000 Oct 11, 2018 Issue: Health Issues
-
$20,000 Jul 10, 2018 Issue: Health Issues
-
$20,000 Apr 17, 2018 Issue: Health Issues
-
$20,000 Jan 11, 2018 Issue: Health Issues
-
$20,000 Oct 12, 2017 Issue: Health Issues
-
$20,000 Jul 12, 2017 Issue: Health Issues
-
$20,000 Apr 11, 2017 Issue: Health Issues
-
$14,000 Feb 17, 2017 Issue: Health Issues
-
$20,000 Oct 06, 2016 Issue: Health Issues
-
$20,000 Jul 19, 2016 Issue: Health Issues
-
$20,000 Apr 19, 2016 Issue: Health Issues
-
$20,000 Jan 19, 2016 Issue: Health Issues
-
$20,000 Oct 20, 2015 Issue: Health Issues
-
$20,000 Jul 16, 2015 Issue: Health Issues
-
$20,000 Apr 16, 2015 Issue: Health Issues
-
$20,000 Jan 20, 2015 Issue: Health Issues
-
$20,000 Oct 20, 2014 Issue: Health Issues
-
$20,000 Jul 18, 2014 Issue: Health Issues
-
$20,000 Apr 17, 2014 Issue: Health Issues
-
$20,000 Jan 17, 2014 Issue: Health Issues
-
$20,000 Oct 18, 2013 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of VIVO in WallStreetBets Daily Discussion
Recent insights relating to VIVO
Recent picks made for VIVO stock on CNBC
ETFs with the largest estimated holdings in VIVO
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view VIVO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.